The U.S. Food and Drug Administration (FDA) endorsed a blood test designed to spot early signs of dozens of cancers despite concerns about how definitive the test’s results may be, the Associated ...

One blood draw flagged cancers doctors would usually miss until much later, and most were early enough to still be treatable.

Natera (NASDAQ:NTRA) has received Breakthrough Device Designation from the US Food and Drug Administration (FDA) for its investigational multi-cancer early detection (MCED) blood test, marking a ...

A new type of blood test could help detect multiple cancers early. A team of researchers in California studied a new multi-cancer early detection (MCED) test called Galleri, which can reportedly ...

Researchers from Geneseeq and a network of Chinese academic hospitals have validated a blood test that can detect a broad range of cancers with high accuracy using cell-free DNA. A multi-cancer early ...

A large prospective study reveals multicancer blood testing successfully identifies seventeen malignancies, effectively supplementing routine clinical screening protocols.

A large-scale analysis of 455,530 infection patients shows that routine blood count parameters form distinct site-associated ...

Blood tests alone cannot definitively diagnose non-Hodgkin’s lymphoma, but they can help doctors identify related issues and monitor treatment progress. A typical blood panel for non-Hodgkin’s ...